Yixintang Pharmaceutical Group Co., Ltd. (SHE:002727)

SHE:002727 Revenue

Yixintang Pharmaceutical Group had revenue of 4.43B CNY in the quarter ending March 31, 2026, a decrease of -6.99%. This brings the company's revenue in the last twelve months to 17.00B, down -3.76% year-over-year. In the year 2025, Yixintang Pharmaceutical Group had annual revenue of 17.34B, down -3.69%.

• Revenue (ttm): 17.00B
• Revenue Growth: -3.76%
• P/S Ratio: 0.43
• Revenue / Employee: 466.52K
• Employees: 36,447
• Market Cap: 7.34B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	17.34B	-664.21M	-3.69%
Dec 31, 2024	18.00B	620.14M	3.57%
Dec 31, 2023	17.38B	-51.30M	-0.29%
Jan 1, 2023	17.43B	2.84B	19.50%
Jan 1, 2022	14.59B	1.93B	15.26%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 5, 2026

Data Sources Report a data error